GLMD

Galmed Pharmaceuticals Ltd Cross-source read$3.84 4.71%
Health CareCUSIP M47238148· EOD Sep 11, 2026

Among active 13F managers last quarter, 3 added and 2 reduced; the largest holder to move was Citadel Advisors LLC (+663%). No recent Form 4 insider filings for GLMD.

Tracked 13F holders
14
5 in Q2 2026 filings
13F value (tracked)
$114K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
3 adding · 2 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$3.84 4.71%5Y -99.3%
$0.43$151.95$303.46$454.98$606.492021202220232024202520262323232
Hover for who · click for detailEnd-of-day closing prices52w $0.47 – $4.97

Who owns GLMD?

14 tracked 13F filers · ranked by shares held

14 tracked 13F filers disclose a position in GLMD as of the latest SEC 13F filings, a combined $114K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Citadel Advisors LLC87K
$48K
+663%
Added · +75K sh
Q2 2026
2Two Sigma Investments, LP80K
$39K
−29%
Reduced · −32K sh
Q1 2026
3XTX Topco Ltd22K
$11K
+103%
Added · +11K sh
Q1 2026
4Jane Street Group, LLC16K
$8K
+36%
Added · +4K sh
Q1 2026
5Two Sigma Securities, LLC11K
$6K
−8.0%
Reduced · −959 sh
Q2 2026
6UBS Group AG3K
$1K
+40%
Added · +732 sh
Q1 2026
7BNP Paribas Financial Markets600
$294
−33%
Reduced · −300 sh
Q1 2026
8Morgan Stanley157
$77
−47%
Reduced · −141 sh
Q1 2026
9SBI Securities Co., Ltd.66
$37
+313%
Added · +50 sh
Q2 2026
10Wells Fargo & Company43
$21
+378%
Added · +34 sh
Q1 2026
11Federation des caisses Desjardins du Quebec14
$8
Held
Q2 2026
12Osaic Holdings, Inc.5
$2
Held
Q1 2026
13Allworth Financial LP2
$1
Held
Q1 2026
14Elevation Wealth Partners, LLC1
$1
Held
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is GLMD being bought or sold by institutions?

Last quarter, 3 funds added to an existing position in GLMD, while 2 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Added
3
added to an existing position
Reduced
2
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own GLMD also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA5 funds$4.8B
Alphabet Inc-CL AGOOGL5 funds$2.5B
Microsoft CorpMSFT5 funds$2.0B
Broadcom IncAVGO5 funds$1.8B
Micron Technology IncMU5 funds$1.6B
Berkshire Hathaway Inc-CL BBRK/B5 funds$1.4B
Costco Wholesale CorpCOST5 funds$1.4B
Advanced Micro DevicesAMD5 funds$1.3B
Palantir Technologies Inc-APLTR5 funds$1.2B
Eli Lilly & CoLLY5 funds$1.2B
Meta Platforms Inc-Class AMETA5 funds$1.1B
Applied Materials IncAMAT5 funds$965.6M

Ranked by how many of GLMD's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in GLMD.

Insider activity (Form 4)

No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
64
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
GLMD is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

5 tracked filers in Q2 2026 filingsstill filing
0815Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $54K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

0 most recent

No filings captured for this ticker in the live stream yet.

Keep exploring

Connected entities for GLMD

Browse more

Build

Ask your agent what changed in GLMD

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/GLMD/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for GLMD.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GLMD. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.